Publications – Dei Group International

MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis

Dr. Magoola Matthias is a broad based business entrepreneur and professional chemist with over 15 years of experience working with key areas of expertise in the mining sector and medical research

Unlocking the Future of Drug Development: Generative AI, Digital Twins, and Beyond

Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders

Dr. Magoola Matthias is a broad based business entrepreneur and professional chemist with over 15 years of experience working with key areas of expertise in the mining sector and medical research

Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders

Synergistic Approaches in Neurodegenerative Therapeutics: 2 Multi-Target Drug Innovative Interventions for Alzheimer’s 3 Disease

mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option

Advances in Escherichia coli-Based Therapeutic Protein Expression: Mammalian Conversion, Continuous Manufacturing, and Cell-Free Production

Microbiome Impact on Neurological and Autoimmune Disor- 2 ders: A Novel Healthcare Resolution

Dr. Magoola Matthias is a broad based business entrepreneur and professional chemist with over 15 years of experience working with key areas of expertise in the mining sector and medical research

Harnessing T-cell Immunity for Vaccines: A Comprehensive 2 Review